We use cookies on our websites to ensure the proper functioning of the website and to help provide the best user experience.
By continuing to use our site, you agree to the use of cookies. Learn more about cookies here.


Success story: European Colorectal Cancer rates decline due to improved diagnosis and disease management

Recent research(1) predicts that mortality rates in the European Union for colorectal cancer (CRC) will decline by 6.7% in men and by 7.5% in women from 2012 to 2018. Professor Carlo La Vecchia, who led the research, said in a press release(2) that the predicted fall in CRC deaths "has been one of the major success stories in clinical oncology" and that this decline "is due to improved diagnosis and management of the disease".

In a study published in the leading cancer journal Annals of Oncology in March 19, researchers predict that death rates in the European Union for most cancers will continue to fall this year, compared to 2012.


  1. European cancer mortality predictions for the year 2018 with focus on colorectal cancer. Ann Oncol 2018, https://doi.org/10.1093/annonc/mdy033
  2. European Society for Medical Oncology. Annals of Oncology Press Release: Decline in Colorectal Cancer Deaths is a "Major Success" Story; Seven per Cent Fall in Death Rates Since 2012. Press release published 19 March 2018. http://www.esmo.org/Press-Office/Press-Releases/Decline-in-Colorectal-Cancer-Deaths-is-a-Major-Success-Story-Seven-per-Cent-Fall-in-Death-Rates-Since-2012


QuikRead go iFOBT is a faecal immunochemical test for detection and quantification of haemoglobin (Hb) in faeces. Read more on QuikRead go iFOBT test